# Oncolytics Biotech Inc: Form 8-K, filed Mar 20, 2026

- Company: [Oncolytics Biotech Inc](/companies/oncy.md) (CIK 1129928)
- Form: 8-K
- Filed: 2026-03-20
- Accepted by EDGAR: Mar 20, 2026, 16:43 ET
- Period: 2026-03-17
- Accession: 0001104659-26-032763
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1129928/000110465926032763/tm269428d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1129928/000110465926032763/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1129928/000110465926032763/tm269428d1_8k.htm

Filed Mar 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-032763. Last ingested by Listed: Nov 9, 2026, 18:55 ET. No prices; not investment advice.